TR199901722T2 - 1-$4-(3-Trifloro metilfenil)-1,2,3,6-tetrahidro pirid-1-il]-2-(6,7-dimetoksi naft-2-il)etan'�n n�rotropik etkisi olan ila�lar�n haz�rlanmas�nda kullan�lmas� - Google Patents
1-$4-(3-Trifloro metilfenil)-1,2,3,6-tetrahidro pirid-1-il]-2-(6,7-dimetoksi naft-2-il)etan'�n n�rotropik etkisi olan ila�lar�n haz�rlanmas�nda kullan�lmas�Info
- Publication number
- TR199901722T2 TR199901722T2 TR1999/01722T TR9901722T TR199901722T2 TR 199901722 T2 TR199901722 T2 TR 199901722T2 TR 1999/01722 T TR1999/01722 T TR 1999/01722T TR 9901722 T TR9901722 T TR 9901722T TR 199901722 T2 TR199901722 T2 TR 199901722T2
- Authority
- TR
- Turkey
- Prior art keywords
- trifluoromethylphenyl
- ethane
- dimethoxynaphth
- tetrahydropyrid
- drug
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 title 1
- 230000002276 neurotropic effect Effects 0.000 title 1
- ZSIWSMBTYGCGCL-UHFFFAOYSA-N 1-[2-(6,7-dimethoxynaphthalen-2-yl)ethyl]-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2h-pyridine Chemical compound C1=C2C=C(OC)C(OC)=CC2=CC=C1CCN(CC=1)CCC=1C1=CC=CC(C(F)(F)F)=C1 ZSIWSMBTYGCGCL-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR1997/000202 WO1998033502A1 (fr) | 1997-02-03 | 1997-02-03 | Utilisation du 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane pour la preparation de medicaments destines aux traitements de troubles cerebraux et neuronaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199901722T2 true TR199901722T2 (xx) | 2000-08-21 |
Family
ID=9502506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/01722T TR199901722T2 (xx) | 1997-02-03 | 1997-02-03 | 1-$4-(3-Trifloro metilfenil)-1,2,3,6-tetrahidro pirid-1-il]-2-(6,7-dimetoksi naft-2-il)etan'�n n�rotropik etkisi olan ila�lar�n haz�rlanmas�nda kullan�lmas� |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0954311A1 (cs) |
| JP (1) | JP2001511141A (cs) |
| AU (1) | AU1607397A (cs) |
| CA (1) | CA2279326A1 (cs) |
| CZ (1) | CZ275399A3 (cs) |
| EE (1) | EE9900332A (cs) |
| HU (1) | HUP0000767A3 (cs) |
| IL (1) | IL130994A0 (cs) |
| IS (1) | IS5117A (cs) |
| TR (1) | TR199901722T2 (cs) |
| WO (1) | WO1998033502A1 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6272180B1 (en) * | 1997-11-21 | 2001-08-07 | Sharp Laboratories Of America, Inc. | Compression and decompression of reference frames in a video decoder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| US5618822A (en) * | 1990-05-23 | 1997-04-08 | Sanofi | N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| FR2662442A1 (fr) * | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
-
1997
- 1997-02-03 HU HU0000767A patent/HUP0000767A3/hu unknown
- 1997-02-03 EP EP97902426A patent/EP0954311A1/fr not_active Withdrawn
- 1997-02-03 TR TR1999/01722T patent/TR199901722T2/xx unknown
- 1997-02-03 CZ CZ992753A patent/CZ275399A3/cs unknown
- 1997-02-03 JP JP53257498A patent/JP2001511141A/ja active Pending
- 1997-02-03 EE EEP199900332A patent/EE9900332A/xx unknown
- 1997-02-03 AU AU16073/97A patent/AU1607397A/en not_active Abandoned
- 1997-02-03 CA CA002279326A patent/CA2279326A1/fr not_active Abandoned
- 1997-02-03 WO PCT/FR1997/000202 patent/WO1998033502A1/fr not_active Ceased
- 1997-02-03 IL IL13099497A patent/IL130994A0/xx unknown
-
1999
- 1999-07-15 IS IS5117A patent/IS5117A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0954311A1 (fr) | 1999-11-10 |
| CZ275399A3 (cs) | 1999-12-15 |
| IL130994A0 (en) | 2001-01-28 |
| CA2279326A1 (fr) | 1998-08-06 |
| EE9900332A (et) | 2000-02-15 |
| AU1607397A (en) | 1998-08-25 |
| WO1998033502A1 (fr) | 1998-08-06 |
| HUP0000767A3 (en) | 2000-10-30 |
| IS5117A (is) | 1999-07-15 |
| JP2001511141A (ja) | 2001-08-07 |
| HUP0000767A2 (hu) | 2000-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| HUP0301868A2 (hu) | Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz | |
| DK0644932T3 (da) | Oprensede former af DNase | |
| DE60230591D1 (de) | Glykopyranosyloxypyrazolderivate und deren medizinische verwendung | |
| DE60237580D1 (de) | Glykopyranosyloxypyrazolderivate und deren medizinische verwendung | |
| DE59912910D1 (de) | Verwendung von Nanodispersionen in pharmazeutischen Endformulierungen | |
| ATE243196T1 (de) | Piperidine und pyrrolidine | |
| DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
| EP1001782A4 (en) | 5,6-HETEROARYL-DIPYRIDO 2,3- $ i (b): 3 ', 2' - $ i (f)] AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION | |
| ATE420097T1 (de) | Substituierte sapogenine und ihre verwendung | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| DE68904922D1 (de) | Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung. | |
| DE60214846D1 (de) | Verwendung von mGLuR5 antagonists zur Herstellung von Medikamenten zur Behandlung von empfindlichen X Syndrome, Autismus und geistiger Zurückgebliebenheit | |
| ATE226947T1 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung | |
| MX9301136A (es) | Composiciones que contienen psyllium. | |
| HUP9800938A2 (hu) | NK-1 receptor antagonisták alkalmazása irritációs bélszindróma tüneteinek kezelésére | |
| BR9807523A (pt) | Quinoxalinas em combinação tripla com inibidores da protease e inibidores de transcriptase reversa como medicamentos para o tratamento de aids. | |
| PE11399A1 (es) | Combinacion de loratadina y un descongestionante para el tratamiento del asma | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| EP1663201A4 (en) | USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência | |
| EP1461056A4 (en) | PROCESS FOR THE PREPARATION AND USE OF POLYOXYETHYLIC CASTOR OIL IN PHARMACEUTICAL COMPOSITIONS | |
| BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
| TR199901722T2 (xx) | 1-$4-(3-Trifloro metilfenil)-1,2,3,6-tetrahidro pirid-1-il]-2-(6,7-dimetoksi naft-2-il)etan'�n n�rotropik etkisi olan ila�lar�n haz�rlanmas�nda kullan�lmas� | |
| BR9814188A (pt) | "agonistas de 5-ht1f" |